Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza

  • M. D Heath1Email author,
  • N. J. Swan1,
  • A. C. Marriott2,
  • N. J. Silman2,
  • B. Hallis2,
  • C. Prevosto2, 3,
  • K. E. Gooch2 and
  • M. A. Skinner1
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:232

https://doi.org/10.1186/s12879-017-2329-5

Received: 9 March 2016

Accepted: 17 March 2017

Published: 27 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
9 Mar 2016 Submitted Original manuscript
11 Jun 2016 Reviewed Reviewer Report - Nikolai Petrovsky
5 Jul 2016 Reviewed Reviewer Report - Claudia Maria Trombetta
25 Jul 2016 Reviewed Reviewer Report - Ming Hsi Huang
29 Jul 2016 Author responded Author comments - Matthew Heath
Resubmission - Version 2
29 Jul 2016 Submitted Manuscript version 2
1 Sep 2016 Reviewed Reviewer Report - Claudia Maria Trombetta
4 Nov 2016 Author responded Author comments - Matthew Heath
Resubmission - Version 3
4 Nov 2016 Submitted Manuscript version 3
14 Nov 2016 Reviewed Reviewer Report - Daniela Amicizia
29 Nov 2016 Reviewed Reviewer Report - Claudia Maria Trombetta
20 Feb 2017 Author responded Author comments - Matthew Heath
Resubmission - Version 4
20 Feb 2017 Submitted Manuscript version 4
Publishing
17 Mar 2017 Editorially accepted
27 Mar 2017 Article published 10.1186/s12879-017-2329-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Allergy Therapeutics Ltd, Dominion Way, West Sussex, UK
(2)
Public Health England, PHE Porton, Salisbury, UK
(3)
Present address: Kings College, Guys Campus, London, UK

Advertisement